SCHEMBL18954535

SCHEMBL18954535

CCOC(=O)CCCN1C(=O)C(=O)c2cc([N+](=O)[O-])ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP1 P29466 2/20 0.52
▸ CASP3 P42574 2/20 0.52
▸ CASP4 P49662 2/20 0.52
▸ CASP7 P55210 2/20 0.52
▸ CASP9 P55211 2/20 0.52
▸ CASP6 P55212 2/20 0.52
▸ ALDH1A1 P00352 7/20 0.52
▸ CASP8 Q14790 1/20 0.51
▸ MAPT P10636 4/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ TDP1 Q9NUW8 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ TNF P01375 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954612 0.84 ALDH1A1 (0.73) ALDH1A1MAPTKDM4ETDP1KMT2A
SCHEMBL11570788 0.82 CASP3 (0.63) CASP1CASP3CASP4CASP7CASP9
SCHEMBL18954685 0.82 PARK7 (0.58) ALDH1A1MAPTKDM4ETDP1KMT2A
SCHEMBL18955310 0.82 ALDH1A1 (0.56) CASP3ALDH1A1MAPTKDM4ETDP1
SCHEMBL18954676 0.82 ALDH1A1 (0.56) ALDH1A1MAPTKDM4ETDP1KMT2A
SCHEMBL18955190 0.81 CA1 (0.54) CASP3CASP7ALDH1A1CA12CA1
SCHEMBL916697 0.81 ALDH1A1 (0.52) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL18955347 0.81 ALDH1A1 (0.53) CASP1CASP3CASP7CASP6ALDH1A1
SCHEMBL18955348 0.81 ALDH1A1 (0.53) CASP1CASP3CASP7CASP6ALDH1A1
SCHEMBL19032878 0.81 CASP3 (0.62) CASP1CASP3CASP4CASP7CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback